Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2007 | 07-2007 | 04-2007 | 01-2007 | 10-2006 | |
| Sales | 211 | 0 | 893 | 904 | 895 |
| Cost of Goods | 1,111 | N/A | 1,990 | 1,418 | 1,057 |
| Gross Profit | -900 | N/A | -1,098 | -514 | -162 |
| Operating Expenses | 1,543 | 0 | 1,934 | 3,467 | 1,017 |
| Operating Income | -2,332 | N/A | -2,042 | -3,563 | -1,122 |
| Other Income | -228 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -2,560 | 0 | -2,042 | -3,563 | -1,122 |
| Net Income Continuous | -2,560 | N/A | -2,042 | -3,563 | -1,122 |
| Net Income | $-2,560 | $N/A | $-2,042 | $-3,563 | $-1,122 |
| EPS Basic Total Ops | -0.32 | N/A | -0.25 | -0.44 | -0.14 |
| EPS Basic Continuous Ops | -0.32 | N/A | -0.25 | -0.44 | -0.14 |
| EPS Diluted Total Ops | -0.32 | N/A | -0.25 | -0.44 | -0.14 |
| EPS Diluted Continuous Ops | -0.32 | N/A | -0.25 | -0.44 | -0.14 |
| EBITDA(a) | $-2,314 | $N/A | $-1,991 | $-3,545 | $-1,102 |